
GLP-1 medications have revolutionized weight loss.
Designed for chronic weight management and to treat type 2 diabetes, glucagon-like peptide-1 receptor agonists such as Ozempic, Mounjaro and Wegovy essentially work by promoting weight loss through increased fullness and reduction of appetite.